CompanyDeals

Jacobio Pharma Receives RMB 172 Million Milestone Payment from Allist Pharmaceuticals

CompanyDeals

Apeloa Pharmaceutical Partners with Biocre Tech to Boost Pharmaceutical Innovation

CompanyDeals

FDA Approves Cobenfy as Novel Schizophrenia Treatment with First-in-Decades Mechanism

Policy / Regulatory

Hunan Province Includes Fertility Treatments in Medical Insurance Coverage from October 2024

CompanyDeals

Shanghai Junshi Biosciences Inks Licensing Deal for IAMA-001 Nasal Spray with Nanjing JSIAMA

Company

China’s Pharmaceutical Industry Sees Mixed Results in H1 2024, CAPEM Data Reveals

Policy / Regulatory

Shanghai Medical Procurement Platform Sets Price Cap for Non-Locally Supplied Drugs

CompanyDeals

Pfizer Partners with Shanghai Pharmaceutical for Long-Term Vaccine Collaboration in China

Drug

FDA Panel Weighs in on Narrowing Use of PD-1 Inhibitors in Stomach and Esophageal Cancers

CompanyDrug

2seventy bio and BMS Discontinue Phase III Trial for Multiple Myeloma Therapy Abecma

CompanyDrug

Zelgen Biopharmaceuticals Receives NMPA Approval for ZG005 Clinical Trial in Advanced Solid Tumors

Company

Johnson & Johnson Reportedly Winding Down Cardiovascular and Metabolic Pharma Unit